AI주식인사이트AI Stock Insight
C

제노레이

122310KOSDAQ

45.5 / 100

Reference Date: 2026-09-08

Financial Score19.0 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 3.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Genoray develops, manufactures, and sells X-ray imaging diagnostic equipment for medical and dental environments. The company operates both medical (C-arm, Mammography) and dental (Panorama, CT, Portable) segments, uniquely being the only South Korean firm offering both. The medical segment focuses on real-time imaging during surgeries and breast disease diagnosis, while the dental segment provides high-resolution 3D imaging technology for dental treatments and implant surgery.

Number of Employees

358people

Average Salary

56.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
54.10Industry Average 15.000.0Point

3.6x industry avg (risky)

PBR
0.57Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
0.74Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
8.99Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.1% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼76.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 3.8% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 3,300Won52-week high 5,29052-week low 3,200
1-month return2.0Point

1m -3.51% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-28
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral기업설명회(IR)개최2026-08-12